Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin E

American Journal of Physiology. Heart and Circulatory Physiology
Juan AsbunFrancisco J Villarreal

Abstract

Long-standing diabetes can result in the development of cardiomyopathy, which can be accompanied by myocardial fibrosis. Although exposure of cultured kidney and skin fibroblasts to high glucose (HG) concentration is known to increase collagen synthesis, little is known about cardiac fibroblasts (CFs). Therefore, we determined the influence of HG conditions on CF functions and the effects of losartan and vitamin E in these responses. We cultured rat CFs in either normal glucose (NG; 5.5 mM) or HG (25 mM) media and assessed changes in protein and collagen synthesis, matrix metalloproteinase (MMP) activity, and levels of mRNA for ANG II type 1 (AT(1)) receptors. Results indicate that HG-level CFs synthesized more protein and collagen, and these effects were not due to changes in osmotic pressure. The addition of ANG II stimulated protein and collagen synthesis in NG-concentration but not HG-concentration CFs. Interestingly, losartan pretreatment blocked the HG- or ANG II-induced increases in both protein and collagen synthesis. HG or ANG II decreased total MMP activity. Decreases in MMP activity were blocked by losartan. AT(1) mRNA levels were upregulated with HG concentration. Vitamin E pretreatment blocked the effects of HG on ...Continue Reading

References

Oct 1, 1992·The American Journal of Physiology·D E DostalK M Baker
Jun 1, 1995·Clinical Cardiology·A Shehadeh, T J Regan
Jan 1, 1994·Methods in Enzymology·E A Serbinova, L Packer
Dec 16, 1998·Clinical Cardiology·K S Spector
Jan 20, 1999·Cardiovascular Research·N S DhallaN Takeda
Dec 10, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·S C JonesC A Pollock
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
May 9, 2000·Progress in Lipid Research·A Azzi, A Stocker
Jun 27, 2000·The Journal of Nutrition·A AzziJ M Zingg
Dec 21, 2000·American Journal of Physiology. Cell Physiology·D A SiwikW S Colucci
Nov 9, 2001·Japanese Journal of Pharmacology·E L RhodenC R Rhoden
Jan 15, 2002·American Journal of Physiology. Renal Physiology·Soo Hyun Park, Ho Jae Han
Jan 17, 2002·Pediatric Surgery International·Engin GünelMurat Tosun
Aug 27, 2002·Journal of Hypertension·Lars H LindholmUNKNOWN LIFE study group
Oct 18, 2002·Revista española de cardiología·Manuel Anguita Sánchez
Nov 5, 2002·The American Journal of Pathology·Yao SunKarl T Weber
Nov 16, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Chhinder P SodhiAtul Sahai
Jan 31, 2003·Cardiovascular Diabetology·Christophe BautersPascal de Groote
Mar 5, 2003·Journal of Biochemical and Molecular Toxicology·A C MaritimJ B Watkins
Sep 6, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Subrina JesminAkira Kitabatake

❮ Previous
Next ❯

Citations

Oct 12, 2012·Journal of Cardiovascular Translational Research·Katrina Go YamazakiAlexander C Zambon
Nov 26, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Boglarka LaczyJohn C Chatham
Jun 25, 2014·Canadian Journal of Physiology and Pharmacology·Patricia E ShamhartCharles K Thodeti
Jun 2, 2009·Frontiers in Bioscience (Scholar Edition)·Marcin Dobaczewski, Nikolaos Georgios Frangogiannis
Aug 8, 2007·Journal of the Cardiometabolic Syndrome·Melvin R HaydenJames R Sowers
Jan 22, 2013·Life Sciences·Vennece FowlkesEdie C Goldsmith
Feb 21, 2006·Journal of the American College of Cardiology·Juan Asbun, Francisco J Villarreal
Sep 25, 2012·Life Sciences·Forough MohammadzadehThomas G Parker
Dec 19, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Cheng Xue QinRebecca H Ritchie
Feb 21, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Nicole E HastingsBrett R Blackman
Sep 13, 2007·In Vitro Cellular & Developmental Biology. Animal·Xiaoyi ZhangWayne E Carver
Mar 19, 2008·Basic Research in Cardiology·Sophie Van LinthoutCarsten Tschöpe
Feb 10, 2017·Pharmacological Reports : PR·George J Dugbartey
May 25, 2007·Connective Tissue Research·Paul E NormanJonathan Golledge
Mar 4, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Kaliyamurthi VenkatachalamBysani Chandrasekar
Feb 26, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Vivek P SinghRajesh Kumar
Aug 27, 2009·American Journal of Physiology. Endocrinology and Metabolism·Patricia E ShamhartJ Gary Meszaros
Aug 31, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Gaku OguriIssei Komuro
Feb 7, 2020·International Journal of Molecular Sciences·Scott P Levick, Alexander Widiapradja
Feb 21, 2014·American Journal of Physiology. Cell Physiology·Hugo AguilarIsrael Ramirez-Sanchez
Jun 26, 2013·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Meng RenLi Yan
Dec 31, 2020·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Izabela Tuleta, Nikolaos G Frangogiannis
Jan 26, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Ju-Chi LiuHong-Jye Hong
Dec 24, 2010·Journal of Agricultural and Food Chemistry·Anangelina C Archile-ContrerasPeter P Purslow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.